Loading...
Loading...
Among the 7 tracked institutional investors we monitor, IBRX (IMMUNITYBIO INC) is held with a combined value of $454.73M across 83,602,529 shares. The largest holder is BlackRock, Inc. with a position worth $202.08M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 5 funds increased their holdings.
Total Institutional Value
$454.73M
Total Shares Held
83,602,529
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $202.08M | 0.00% | +2.9% |
| 2 | STATE STREET CORP | $135.82M | 0.00% | +7.6% |
| 3 | VANGUARD GROUP INC | $64.90M | 0.00% | New |
| 4 | CITADEL ADVISORS LLC | $39.39M | 0.01% | +207.2% |
| 5 | MILLENNIUM MANAGEMENT LLC | $11.08M | 0.00% | +1119.3% |
| 6 | Point72 Asset Management, L.P. | $1.23M | 0.00% | New |
| 7 | FMR LLC | $235.50K | 0.00% | +126.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of IBRX with a position worth $202.08M, representing 0.00% of their portfolio. In total, 7 institutional investors hold IBRX with a combined value of $454.73M.
In the most recent quarter, 2 funds opened a new position in IBRX. Additionally, 5 increased their holdings.
Institutional investors hold $454.73M worth of IBRX stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $202.08M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IBRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IBRX positions.